Evaluation of the effectiveness of antimicrobial stewardship interventions in paediatric patients with community-acquired pneumonia: impact on the length of hospital stay

Keywords: Humans, Child, Community-Acquired Pneumonia, Antimicrobial Stewardship, Length of Stay

Abstract

community-acquired pneumonia remains one of the leading causes of paediatric hospitalization worldwide, especially in resource-limited settings. Prolonged hospital stay imposes an additional burden on the healthcare system, negatively affects the psychological wellbeing of both the child and their family, increases the risk of hospital-acquired infections, and is associated with significant financial losses for households. Optimizing the duration of antibacterial therapy through antimicrobial stewardship programs enables the reduction of hospitalization length without compromising clinical outcomes. The aim of this study was to evaluate the effectiveness of a set of antimicrobial stewardship interventions implemented in clinical practice in paediatric patients with community-acquired pneumonia. A comparative analysis of medical records of children hospitalized in 2023 (before the interventions) and in 2025 (after the interventions) at a medical facility in Kyiv was conducted. A total of 138 cases were analysed (48 in 2023 and 90 in 2025). The interventions included the development and approval of a standard operating procedure (a set of instructions that helps standardise a process to reduce the likelihood of error) for prescribing antimicrobials for paediatric community-acquired pneumonia, prospective audit of prescriptions, and healthcare staff training. The data were statistically processed using MedStat v.5.2 software with Student’s t-test for independent samples. Following the interventions, the average hospital stay significantly decreased from 9.48 ± 0.77 days to 6.8 ± 0.34 days (p < 0.001). A reduction was observed in in children under 5 years of age (from 9.9 ± 0.83 to 6.23 ± 0.59 days, p < 0.001), and a downward trend was noted in patients 5 years of age and older (from 8.78 ± 1.57 to 7.03 ± 0.42 days, p = 0.035). The proportion of short-term hospitalizations (up to 7 days) increased from 10.4% to 33.3% (p = 0.003), while prolonged stays over 10 days decreased from 35.4% to 2.2% (p < 0.001). The results demonstrate a positive impact of implemented antimicrobial interventions on the duration of hospitalization in paediatric patients with community-acquired pneumonia. The study supports the rationale for systematic integration of antimicrobial stewardship practices in healthcare facilities as an effective clinical and potentially cost-efficient approach to improving the quality of care.

References

Tsoumani E, Carter JA, Salomonsson S, Stephens JM, Bencina G. Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review. Expert Rev Vaccines. 2023;22(1):876-884. doi: 10.1080/14760584.2023.2261785.

Vaughn VM, Dickson RP, Horowitz JK, Flanders SA. Community-acquired pneumonia: a review. JAMA. 2024;332(15):1282-1295. doi: 10.1001/jama.2024.14796.

Fonseca Lima EJ, Mello MJ, Albuquerque MF, Lopes MI, Serra GH, Lima DE et al. Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study. BMC Pediatr. 2016;16(1):157. doi: 10.1186/s12887-016-0695-6.

Meyer Sauteur PM. Childhood community-acquired pneumonia. Eur J Pediatr. 2024;183(3):1129-1136. doi: 10.1007/s00431-023-05366-6.

Pernica JM, Harman S, Kam AJ, Carciumaru R, Vanniyasingam T, Crawford T et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: The SAFER randomized clinical trial. JAMA Pediatr. 2021;175(5):475-482. doi: 10.1001/jamapediatrics.2020.6735.

Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D et al. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. JAMA. 2021;326(17):1713-1724. doi: 10.1001/jama.2021.17843.

Williams DJ, Creech CB, Walter EB, Martin JM, Gerber JS, Newland JG et al.

Short vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr. 2022;176(3):253 261. doi: 10.1001/jamapediatrics.2021.5547

McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH et al. Extended versus standard antibiotic course duration in children <5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a multicenter, double-blind, parallel, superiority randomized controlled trial. Pediatr Infect Dis J. 2022;41(7):549-555. doi: 10.1097/INF.0000000000003558.

Puzz L, Plauche EA, Cretella DA, Harrison VA, Wingler MJB. Evaluation of a pediatric community-acquired pneumonia antimicrobial stewardship intervention at an academic medical center. Antibiotics (Basel). 2023;12(4):780. doi: 10.3390/antibiotics12040780.

Dinku H, Amare D, Mulatu S, Abate MD. Predictors of prolonged hospitalization among children aged 2–59 months with severe community-acquired pneumonia in public hospitals of Benishangul-Gumuz region, Ethiopia: a multicenter retrospective follow-up study. Front Pediatr. 2023;11:1189155. doi: 10.3389/fped.2023.1189155

Dighriri IM, Alnomci BA, Aljahdali MM, Althagafi HS, Almatrafi RM, Altwairqi WG et al. The role of clinical pharmacists in antimicrobial stewardship programs (ASPs): a systematic review. Cureus. 2023;15(12):e50151. doi: 10.7759/cureus.50151.

Abo YN, Freyne B, Kululanga D, Bryant PA. The impact of antimicrobial stewardship in children in low- and middle-income countries: a systematic review. Pediatr Infect Dis J. 2022;41(3S):S10-S17. doi: 10.1097/INF.0000000000003317.

Harun MGD, Sumon SA, Hasan I, Akther FM, Islam MS, Anwar MMU. Barriers, facilitators, perceptions and impact of interventions in implementing antimicrobial stewardship programs in hospitals of low-middle and middle countries: a scoping review. Antimicrob Resist Infect Control. 2024;13(1):8. doi: 10.1186/s13756-024-01369-6.

Instructions on the implementation of antimicrobial drug administration in healthcare facilities providing medical care in inpatient settings. On the organization of infection prevention and infection control in healthcare facilities and institutions/institutions providing social services/social protection of the population. 2021; Section 7, article 3.

Zhang S, Sammon PM, King I, Andrade AL, Toscano CM, Araujo SN et al. Cost of management of severe pneumonia in young children: systematic analysis. J Glob Health. 2016;6(1):010408. doi: 10.7189/jogh.06.010408.

Published
2025-09-29
How to Cite
1.
Rafalskyi V, Khaitovych M. Evaluation of the effectiveness of antimicrobial stewardship interventions in paediatric patients with community-acquired pneumonia: impact on the length of hospital stay. USMYJ [Internet]. 2025Sep.29 [cited 2026Mar.21];157(3):131-6. Available from: https://mmj.nmuofficial.com/index.php/journal/article/view/576